Tukaram Mundhe's latest action plan on medical devices: MRP vs procurement prices revealed
After cracking down on Mumbai's food sector, Maharashtra FDA Commissioner Tukaram Mundhe has turned to medical device pricing. A state survey found markups of up to 2,841% over procurement prices, prompting Mundhe to seek a review of pricing rules.
Maharashtra Food and Drugs Administration (FDA) Commissioner Tukaram Mundhe has initiated action against exorbitant pricing of medical devices in the state, revealing markups of up to 2,841% between procurement costs and maximum retail prices (MRP). The survey conducted by the state government found that certain hospital surgical consumables and devices were being sold at such inflated prices, particularly in private hospitals.
Mundhe has written to the Department of Pharmaceuticals and the National Pharmaceutical Pricing Authority (NPPA) to review these findings and propose actions, including capping trade margins and regulating essential categories of medical devices under structured price monitoring. The issue goes beyond mere pricing, as it raises concerns about patient protection due to the significant asymmetry of information, with patients often unaware of the true procurement costs of medical devices used during their hospitalization.
Brief written by urgent.news from Live Mint's own syndicated text. Machine-written — may contain errors; check the original before relying on it.
